Estimates Revisions Armata Pharmaceuticals, Inc.
Stocks
ARMP
US04216R1023
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:00 16/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.070 USD | -7.50% |
|
-24.77% | -35.19% |
| 09-14 | Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment | DJ |
| 09-14 | Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ARMP Stock
- Consensus Armata Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
